Table 2: Existing drugs that are approved or investigated for clinical use and that can target some of the enzymes predicted in this study as causing metabolism-based reduction of SARS-CoV-2 biomass production. Information is collated from DrugBank database (Wishart 2018). The reaction abbreviations are as in Table 1.